1. Home
  2. LRMR vs CFBK Comparison

LRMR vs CFBK Comparison

Compare LRMR & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • CFBK
  • Stock Information
  • Founded
  • LRMR N/A
  • CFBK 1892
  • Country
  • LRMR United States
  • CFBK United States
  • Employees
  • LRMR N/A
  • CFBK N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • CFBK Major Banks
  • Sector
  • LRMR Health Care
  • CFBK Finance
  • Exchange
  • LRMR Nasdaq
  • CFBK Nasdaq
  • Market Cap
  • LRMR 191.4M
  • CFBK 154.9M
  • IPO Year
  • LRMR N/A
  • CFBK 1998
  • Fundamental
  • Price
  • LRMR $3.09
  • CFBK $24.20
  • Analyst Decision
  • LRMR Strong Buy
  • CFBK Buy
  • Analyst Count
  • LRMR 7
  • CFBK 1
  • Target Price
  • LRMR $17.86
  • CFBK $29.00
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • CFBK 36.8K
  • Earning Date
  • LRMR 08-06-2025
  • CFBK 08-05-2025
  • Dividend Yield
  • LRMR N/A
  • CFBK 1.16%
  • EPS Growth
  • LRMR N/A
  • CFBK N/A
  • EPS
  • LRMR N/A
  • CFBK 2.28
  • Revenue
  • LRMR N/A
  • CFBK $47,663,000.00
  • Revenue This Year
  • LRMR N/A
  • CFBK $35.39
  • Revenue Next Year
  • LRMR N/A
  • CFBK $10.11
  • P/E Ratio
  • LRMR N/A
  • CFBK $10.58
  • Revenue Growth
  • LRMR N/A
  • CFBK 1.22
  • 52 Week Low
  • LRMR $1.61
  • CFBK $18.33
  • 52 Week High
  • LRMR $11.20
  • CFBK $31.17
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 60.78
  • CFBK 64.99
  • Support Level
  • LRMR $2.81
  • CFBK $23.30
  • Resistance Level
  • LRMR $3.19
  • CFBK $24.39
  • Average True Range (ATR)
  • LRMR 0.30
  • CFBK 0.37
  • MACD
  • LRMR 0.01
  • CFBK 0.04
  • Stochastic Oscillator
  • LRMR 82.43
  • CFBK 78.76

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: